Literature DB >> 15958742

The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation.

Caroline R Sussman1, Timothy Vartanian, Robert H Miller.   

Abstract

Neuregulin is required for proper oligodendrocyte development, but which receptors are involved and whether neuregulin promotes or inhibits maturation remain controversial. To assess the roles of the neuregulin receptor ErbB4 in oligodendrocyte development, we examined oligodendrocyte initiation and maturation in cultures derived from erbB4 knock-out mice and rat spinal cord in the presence of neutralizing erbB4 antibodies. No differences in the development of O4+ oligodendrocytes were detected in the presence or absence of erbB4 signaling. All four epidermal growth factor receptor family members were detected in the ventral neural tube at approximately the time of initial oligodendrocyte development, consistent with redundancy in neuregulin receptor signaling at the onset of oligodendrocyte development. In contrast, greater numbers of differentiated (monoclonal antibody O1+) oligodendrocytes developed in neural tube explants from erbB4(-/-) mice than either erbB4(+/+) or erbB4(+/-) littermates as well as in cultures treated with anti-erbB4. These data indicate that ErbB4 is not required for oligodendrocyte development and, in fact, inhibits oligodendrocyte lineage maturation. Together with previous studies, these data suggest a model in which early oligodendrocyte lineage development is regulated by promiscuous neuregulin receptor signaling, but subsequent lineage progression occurs through a balance of receptor-specific promotion or inhibition of maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958742      PMCID: PMC6724872          DOI: 10.1523/JNEUROSCI.4748-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

Review 1.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 2.  Remyelination strategies: new advancements toward a regenerative treatment in multiple sclerosis.

Authors:  Martin Stangel; Corinna Trebst
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 3.  Glial cells: old cells with new twists.

Authors:  Ugo Ndubaku; Maria Elena de Bellard
Journal:  Acta Histochem       Date:  2007-12-18       Impact factor: 2.479

Review 4.  Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responses.

Authors:  Robert J Romanelli; Teresa L Wood
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

Review 5.  Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Authors:  Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann
Journal:  Neonatology       Date:  2007-11-09       Impact factor: 4.035

6.  Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain.

Authors:  Feng Tao; Qun Li; Su Liu; Haiying Wu; John Skinner; Andres Hurtado; Visar Belegu; Orion Furmanski; Ya Yang; John W McDonald; Roger A Johns
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

7.  Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.

Authors:  Bastian G Brinkmann; Amit Agarwal; Michael W Sereda; Alistair N Garratt; Thomas Müller; Hagen Wende; Ruth M Stassart; Schanila Nawaz; Christian Humml; Viktorija Velanac; Konstantin Radyushkin; Sandra Goebbels; Tobias M Fischer; Robin J Franklin; Cary Lai; Hannelore Ehrenreich; Carmen Birchmeier; Markus H Schwab; Klaus Armin Nave
Journal:  Neuron       Date:  2008-08-28       Impact factor: 17.173

8.  Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3β signaling.

Authors:  FuCheng Luo; Kathryn Burke; Christopher Kantor; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

9.  Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns.

Authors:  Insa Hoffmann; Wolfgang Bueter; Katja Zscheppang; Maria-Jantje Brinkhaus; Andrea Liese; Stefan Riemke; Thilo Dörk; Olaf Dammann; Christiane E L Dammann
Journal:  Brain Behav Immun       Date:  2009-09-04       Impact factor: 7.217

10.  Signaling mechanisms regulating myelination in the central nervous system.

Authors:  Jared T Ahrendsen; Wendy Macklin
Journal:  Neurosci Bull       Date:  2013-04-05       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.